Introduction {#s1}
============

Tuberculosis is caused by the bacillus *Mycobacterium tuberculosis* and remains a major challenge to global public health [@pone.0096359-Zaman1]. According to the report of World Health Organization, there were an estimated 8.6 million incident case of tuberculosis and 1.3 million deaths in 2012 [@pone.0096359-Zumla1]. Although one-third of population is infected by *Mycobacterium tuberculosis*, only 10% of those develop clinical disease during their lifetime. Multiple factors contribute to the risk of infection and development of tuberculosis including environmental factors, host--pathogen interactions and genetic factors [@pone.0096359-Bellamy1]. Epidemiological studies indicate that the risk of developing tuberculosis in human is strongly influenced by genetic factors [@pone.0096359-Azad1]. So far, gene polymorphisms of *SLC11A1* (formerly *NRAMP1*), vitamin D receptor, toll-like receptor 2, tumor necrosis factor-alpha and monocyte chemoattractant protein-1 have been identified to be associated with susceptibility of tuberculosis [@pone.0096359-Li1]--[@pone.0096359-Meilang1].

Human *P2X7* gene encoding the P2X7 receptor contains 13 exons and is localized on chromosome 12q24 [@pone.0096359-Sluyter1]. P2X7 receptors are abundantly expressed in macrophages. *Mycobacterium tuberculosis* is a facultative intracellular pathogen and macrophages are the main reservoir for this agent. Activation of P2X7 by adenosine triphosphate (ATP) causes an immediate opening of a cation selective channel, permitting the influx of Ca^2+^ and Na^+^ and the efflux of K^+^. This process results the induction of the caspase cascade, apoptosis, and the activation of phospholipase D. Phospholipase D promotes phagosome--lysosome fusion and causes mycobacterial death [@pone.0096359-Humphreys1]--[@pone.0096359-CoutinhoSilva1].

Previous studies reported that various single-nucleotide polymorphisms (SNPs) in *P2X7* gene lead to the loss of receptor function, and the most common SNPs are the 1513A/C and -762T/C [@pone.0096359-Tekin1]. *P2X7* 1513 A/C gene polymorphism has been reported to be significantly associated with increased tuberculosis susceptibility [@pone.0096359-Xiao1]. However, the results from different studies on the association between the *P2X7* -762T/C (rs2393799) polymorphism and pulmonary tuberculosis susceptibility are conflicting [@pone.0096359-Li2]--[@pone.0096359-Mokrousov1]. Meta-analysis is a useful method for combining the results from different studies and providing more reliable conclusions [@pone.0096359-Cohn1]. Therefore, we performed a meta-analysis to investigate the association between the *P2X7*-762T/C gene polymorphism and the risk of pulmonary tuberculosis.

Materials and Methods {#s2}
=====================

Literature Search Strategy {#s2a}
--------------------------

We conducted a systematic search on the PubMed, SCI, Elsevier, China National Knowledge Infrastructure (CNKI) and Wanfang Database (up to December 12, 2013). The following terms were used: ("tuberculosis" or : "TB") and ("*P2X7*" or "*P2RX7*") and ("polymorphism" or "mutation" or "variation"). We also searched the references of the retrieved literatures for additional studies. There was no restriction for time period, sample size, population, language, or types of reports. If more than one article was published using the same case series, only the study with largest sample size was included.

Inclusion and Exclusion Criteria {#s2b}
--------------------------------

Included studies in this meta-analysis met the following criteria: (a) a human case-control study on the association between *P2X7* -762T/C polymorphism and the risks of pulmonary tuberculosis; (b) containing available genotype data in cases and controls for estimating an odds ratio (OR) and 95% confidence interval (CI); (c) genotype distributions of control population were consistent with Hardy-Weinberg equilibrium (HWE). The exclusion criteria were: (a) reviews, letters, editorial articles and case reports; (b) studies on the association between other gene polymorphisms and pulmonary tuberculosis risks.

Data Extraction {#s2c}
---------------

Two investigators (Yi and Cheng) extracted the data from all of the eligible publications according to the inclusion and exclusion criteria. Primary extraction data were reviewed by Zhen, and any disagreement was resolved by discussion among the authors. From each study, the following information was extracted: first author's name, year of publication, study location, sample size, source of control, the genotyping method, the number of genotype frequencies in cases and controls.

Statistical Analysis {#s2d}
--------------------

The association between *P2X7* -762T/C polymorphism and pulmonary tuberculosis risks was estimated by calculating pooled ORs and 95%CI in the allele model (C vs. T), co-dominant model (CC vs. TT and CT vs. TT), dominant model (CC/CT vs. TT), and recessive model (CC vs. CT/TT). Significance of the pooled ORs was determined by Z test (p\<0.05 was considered significant). Heterogeneity among included studies was checked by chi-square-based Q test and I^2^ test [@pone.0096359-Wu2]. If the data showed no heterogeneity (p\>0.05, I^2^\<50%), Mantel--Haenszel fixed effects model was used, otherwise DerSimonian--Laird random effects model was used [@pone.0096359-Zhang1]. Hardy-Weinberg equilibrium (HWE) was also tested for included studies. Sensitivity analyses were performed by omitting certain studies each time. Publication bias was assessed by Begg's adjusted rank correlation test and Egger's regression asymmetry test.p\<0.05 was considered as statistically significant [@pone.0096359-Egger1]. All statistical analyses were performed using RevMan 5.0.23 (Cochrane Library Software, Oxford, UK) and STATA 11.0 Software (StataCorp LP, College Station, TX, USA).

Results {#s3}
=======

Studies Selection Process and Characteristics {#s3a}
---------------------------------------------

A total of 272 studies were retrieved through database searching. After reading the titles and abstracts, 16 potential studies were identified for further investigation. Five studies were excluded for not being relevant to -762 T/C polymorphism. One study was excluded for data overlapping and one study was excluded for not reporting the usable data. One case-control study was excluded for being not consistent with HWE. Finally, 8 studies [@pone.0096359-Li2]--[@pone.0096359-NinoMoreno1], [@pone.0096359-Mokrousov1], [@pone.0096359-Bahari1]--[@pone.0096359-Songane1] were included for data extraction ([Figure 1](#pone-0096359-g001){ref-type="fig"}). Among these studies, 6 studies focused on the association between pulmonary tuberculosis risks and *P2X7* -762T/C polymorphism while other studies enrolled both pulmonary tuberculosis and extra-pulmonary tuberculosis patients. All of the 8 included studies were non-familial case-control studies. There was a total of 2207 subjects with pulmonary tuberculosis 1442 subjects were diagnosed by culture, 479 subjects were diagnosed by smear, and the methods of diagnosis of the rest subjects were not reported ([Table 1](#pone-0096359-t001){ref-type="table"}). Genotype and allele distributions for each case-control study are shown in [Table 2](#pone-0096359-t002){ref-type="table"}.

![Flow diagram of the study selection.](pone.0096359.g001){#pone-0096359-g001}
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###### Characteristics of the case-control studies included in the meta-analysis.

![](pone.0096359.t001){#pone-0096359-t001-1}

  First Author          Year        Population          Genotypingmethod     Cases/Controls   MalePatients (%)   MaleControls (%)   Age ofcases   Age of controls                 Diagnosis method                        Control source
  -------------------- ------ ----------------------- --------------------- ---------------- ------------------ ------------------ ------------- ----------------- ---------------------------------------------- -------------------------------
  Bahari et al.         2013     Caucasian (Iran)           ARMS-PCR            150/150              38                 34          48.97±21.2      45.36±16.1      Clinical symptoms,radiologic, smear, culture        Healthy individuals
  Ben-Selma et al.      2011     African (Tunisia)          PCR-RFLP            168/150             75.6                90          44(14--78)      35(24--55)          Clinical examination,smear, culture          Healthy unrelated donors
  Li et al.             2002     African (Gambia)           PCR-RFLP            323/347             67.4               100           34.7±13.2       30.3±7.5                          Smear                         Healthy unrelated donors
  Mokrousov et al.      2008    Caucasian (Russia)          PCR-RFLP            190/127             47.7               64.7          31.7±11.1       32.2±12.0                        Culture                        Healthy unrelated donors
  Nino-Moreno et al.    2007      Mixed (Mexico)            PCR-RFLP             92/110              50                DNR           46.1±17.6       32.4±12.2                  Radiologic, culture                      Healthy contacts
  Sambasivan et al.     2010     Caucasian (India)          PCR-RFLP            156/100             50.7                57           30.4±18.3       35.6±13.3                   Radiologic, smear                   Healthy unrelated donors
  Singla et al.         2012     Caucasian (India)     Allele-Specific PCR      286/392              63                 55           33.1±15.4       36.4±14.9                          DNR                        Healthy unrelated individuals
  Songane et al.        2012   Caucasian (Indonesia)       Sequencing           842/844             53.4               53.2             33              33          Clinical symptoms,radiologic, smear, culture   Healthy unrelated individuals

Abbreviations and definitions: ARMS PCR, Amplification Refractory Mutation System -Polymerase Chain Reaction; PCR-RFLP, Restriction Fragment Length Polymorphism analysis of PCR amplified fragments;

DNR: data not reported.

10.1371/journal.pone.0096359.t002

###### Distributions of P2X7 -762T/C genotype and allele among TB patients and controls.

![](pone.0096359.t002){#pone-0096359-t002-2}

  Author               Case   Control   Case   Control   HWE                                
  ------------------- ------ --------- ------ --------- ----- ----- ----- ----- ----- ----- ------
  Bahari et al.         25      54       71       6      40    104   104   196   52    248   0.39
  Ben-Selma et al.      95      57       16      85      51    14    247   89    221   79    0.12
  Li et al.            182      118      23      163     140   44    482   164   466   228   0.11
  Mokrousov et al.      17      87       86      16      46    65    121   259   78    176   0.09
  Nino-Moreno et al     52      32       8       51      44    15    136   48    146   74    0.27
  Sambasivan et al.     30      88       38      36      49    15    148   164   121   79    0.8
  Singla et al.         28      115     143      18      143   231   171   401   179   605   0.48
  Songane et al.       248      413     181      255     412   177   909   775   922   766   0.65

Quantitative Data Synthesis {#s3b}
---------------------------

A total of 2207 cases and 2220 controls in 8 case-control studies were pooled together for evaluation of the overall association between *P2X7* -762T/C polymorphism and risk of pulmonary tuberculosis. The pooled OR from all studies indicated no significant association between *P2X7* -762T/C polymorphism and pulmonary tuberculosis risk in allelic model (C vs. T: p = 0.15; OR = 0.83, 95% CI = 0.65--1.07) ([Figure 2](#pone-0096359-g002){ref-type="fig"}). There was no significant association in homozygous model (CC vs. TT: p = 0.23; OR = 0.73, 95% CI = 0.44 to 1.22) or heterozygous model (CT vs. TT: p = 0.57; OR = 0.92, 95% CI = 0.68 to 1.24) ([Figure 3](#pone-0096359-g003){ref-type="fig"}, [4](#pone-0096359-g004){ref-type="fig"}). Similarly, dominant model (CC+CT vs. TT: p = 0.32; OR = 0.84, 95% CI = 0.59 to 1.19) and recessive model (CC vs. CT+TT: p = 0.08; OR = 0.77, 95% CI = 0.57 to 1.04) did not demonstrate any altered risk for pulmonary tuberculosis ([Figure 5](#pone-0096359-g005){ref-type="fig"}, [6](#pone-0096359-g006){ref-type="fig"}).

![Forest plot and ORs with 95% CI of *P2X7* -762T/C polymorphism and pulmonary tuberculosis risk (C vs. T).\
The squares and horizontal lines correspond to the OR and 95% CI for each study. The area of the squares reflects the weight. The diamond represents the summary OR and 95% CI.](pone.0096359.g002){#pone-0096359-g002}

![Forest plot and ORs with 95% CI of *P2X7* -762T/C polymorphism and pulmonary tuberculosis risk (CC vs. CT+TT).](pone.0096359.g003){#pone-0096359-g003}

![Forest plot and ORs with 95% CI of *P2X7* -762T/C polymorphism and pulmonary tuberculosis risk (CC vs. TT).](pone.0096359.g004){#pone-0096359-g004}

![Forest plot and ORs with 95% CI of *P2X7* -762T/C polymorphism and pulmonary tuberculosis risk (CT vs. TT).](pone.0096359.g005){#pone-0096359-g005}

![Forest plot and ORs with 95% CI of *P2X7* -762T/C polymorphism and pulmonary tuberculosis risk (CC+CT vs. TT).](pone.0096359.g006){#pone-0096359-g006}

Subgroup analysis by ethnicity did not detect any significant association between *P2X7*--762 T/C and pulmonary tuberculosis risk in Asians or Caucasians. A summary of results from all comparisons is listed in [Table 3](#pone-0096359-t003){ref-type="table"}.

10.1371/journal.pone.0096359.t003

###### Meta-analysis of *P2X7* gene -762T/C polymorphism and risk of pulmonary TB in each subgroup.

![](pone.0096359.t003){#pone-0096359-t003-3}

  Category            C vs. T                CC vs. TT               CT vs. TT             CC+CT vs. TT            CC vs. CT+TT
  ----------- ----------------------- ----------------------- ----------------------- ----------------------- -----------------------
  Ethnicity                                                                                                   
  Caucasian    0.86 (0.60--1.24), 89   0.79 (0.37--1.68), 87   0.97 (0.57--1.67), 77   0.85 (0.45--1.61), 86   0.81 (0.56--1.19), 79
  African      0.82 (0.57--1.17), 66   0.66 (0.31--1.41), 62   0.82 (0.63--1.08), 0    0.80 (0.56--1.16), 48   0.69 (0.37--1.31), 50
  Mixed          0.70 (0.45--1.07)       0.52 (0.20--1.34)       0.71 (0.39--1.30)       0.66 (0.38--1.16)       0.60 (0.24--1.49)
  Overall      0.83 (0.65--1.07), 84   0.73 (0.44--1.22), 81   0.92 (0.68--1.24), 67   0.84 (0.59--1.19), 79   0.77 (0.57--1.04), 69

Publication Bias {#s3c}
----------------

Begg's funnel plot and Egger's test were used to assess the publication bias of included studies. Publication bias was not observed in Begg's funnel plot. The shape of the funnel plots was symmetrical and the Egger's test did not show any evidence of publication bias. These data indicate that there is no significant publication bias in this meta-analysis.

Test of Heterogeneity {#s3d}
---------------------

Heterogeneity among studies in each model is shown in [Table 3](#pone-0096359-t003){ref-type="table"}. The I^2^ showed a stable variation under all comparisons (C vs. T: I^2^ = 84%; CC vs. TT: I^2^ = 81%; CT vs. TT: I^2^ = 67%; CC vs. CT+TT: I^2^ = 79%; CC+CT vs. TT: I^2^ = 69%). Hence, the random effect model was applied to calculate the pooled ORs and 95%CI. In the subgroup analyses, p value for heterogeneity was not significant under heterozygous, dominant and recessive models of Asian population. However, there were heterogeneity under all comparisons in Caucasian population ([Table 3](#pone-0096359-t003){ref-type="table"}).

Sensitivity Analysis {#s3e}
--------------------

Sensitivity analysis was performed to assess the influence of each individual study on the pooled OR by deleting one single study each time. The results showed that no individual study affected the pooled OR significantly, indicating the stability of this meta-analysis.

Discussion {#s4}
==========

In the present meta-analysis, we show that *P2X7* gene -762T/C polymorphism is not associated with the risk of pulmonary tuberculosis. Subgroup analysis by ethnicity did not detect any significant association between *P2X7*--762 T/C and pulmonary tuberculosis risk in Asians or Caucasians.

Our meta-analysis included a total of 8 case-control studies with 2207 cases and 2220 controls, which is substantially larger than a previous meta-analysis on *P2X7* gene -762T/C polymorphism and pulmonary tuberculosis risk [@pone.0096359-Xiao1]. We performed the comparisons of all genetic models in this meta-analysis, while only allelic frequencies were compared in the previous meta-analysis [@pone.0096359-Xiao1]. The conclusion of our meta-analysis that *P2X7* gene -762T/C polymorphism is not associated with pulmonary tuberculosis risk is consistent with the previous meta-analysis [@pone.0096359-Xiao1].

The polymorphisms in the promoter or coding region of *P2X7* gene may alter its expression or function. However, the -762T/C polymorphism of *P2X7* does not appear to be related with altered receptor expression [@pone.0096359-Li2]--[@pone.0096359-NinoMoreno1]. Li and colleagues found that patients with active tuberculosis exhibited reduced *P2X7* receptor expression levels on mononuclear cells which were recovered during chemotherapy. This suggested that the expression of *P2X7* receptor may be regulated by host- or pathogen-generated inhibitory factors [@pone.0096359-Li2], [@pone.0096359-Bahari1], [@pone.0096359-BenSelma1].

Heterogeneity is a potential problem that might affect the interpretation of the results. Therefore, the control group should conform to HWE to ensure similarity of the population genetic background and the reliability of association analyses. One of the potentially eligible studies did not conform to HWE and was excluded [@pone.0096359-Xiao2]. The heterogeneity could also be caused by ethnic variations, environmental factors and methodological factors in study design. The leave-one-out sensitivity analysis did not affect the results of this pooled analysis, indicating that our results were reliable. There was no publication bias for the association between *P2X7*--762 T/C polymorphism and pulmonary tuberculosis risk.

The present meta-analysis had several limitations. First, we only included the studies published in English and Chinese. Some related studies published in other languages might be missed in our meta-analysis. Second, although the funnel plot and Egger's test did not show any publication bias, the influence of bias in the present analysis could not be completely excluded. A more precise analysis could be performed if more detailed data such as age, sex and exposure of each subject was available.

In conclusion, this meta-analysis indicates that *P2X7* -762T/C polymorphism is not associated with pulmonary tuberculosis risk. Further studies with more stringent design and larger sample size are required to validate this conclusion.
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